REGN Revenue 2026
Annual and quarterly sales data for Regeneron Pharmaceuticals Inc
Latest Annual Revenue
$14.20B
2024-12-31
YoY Growth
+8.3%
vs. previous year
4-Year CAGR
55.6%
compound growth
Annual Revenue History
2024-12-31
$14.20B
YoY Growth
+8.3%
2023-12-31
$13.12B
YoY Growth
+7.8%
2022-12-31
$12.17B
YoY Growth
-24.3%
2021-12-31
$16.07B
YoY Growth
+563.3%
2020-12-31
$2.42B
Quarterly Revenue Breakdown
2025-09-30
$3.75B
2025-06-30
$3.68B
2025-03-31
$3.03B
2024-09-30
$3.72B
2024-06-30
$3.55B
2024-03-31
$3.15B
2023-09-30
$3.36B
2023-06-30
$3.16B
Revenue by Segment
Get Full REGN Financial Analysis
View complete income statements, balance sheets, and AI-powered insights
Frequently Asked Questions
What is REGN's revenue?
REGN (Regeneron Pharmaceuticals Inc) reported $14.20 billion in revenue for 2024-12-31. This represents a 8.3% increase compared to the previous year.
How much revenue does REGN make per year?
Regeneron Pharmaceuticals Inc generates approximately $14.20 billion in annual revenue based on the most recent fiscal year ending 2024-12-31.
Is REGN revenue growing?
Yes, REGN's revenue is growing. The company achieved 8.3% revenue growth year-over-year. Over the past 4 years, revenue has grown at a compound annual growth rate (CAGR) of 55.6%.
What is REGN's quarterly revenue?
REGN reported $3.75 billion in revenue for the most recent quarter (2025-09-30). This is 2.1% higher than the previous quarter.
What are REGN's revenue sources?
REGN's revenue comes from multiple segments: Total Revenue. See the revenue breakdown below for detailed segment analysis.
How does REGN compare to competitors in revenue?
REGN generates $14.20 billion in annual revenue in the Healthcare sector. Compare REGN to competitors using our stock comparison tool to see relative market share and growth rates.
Disclaimer: Revenue data is based on publicly filed financial statements. Historical performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.